EDITORIAL
Accepted on 29 Aug 2025
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Clinical Value, Challenges, and Future Directions
doi 10.3389/fonc.2025.1688480
- 312 views
- Frontiers in Oncology
- Gastrointestinal Cancers: Gastric and Esophageal Cancers
- Research Topics
- The Role of Adjuvant and Neoadjuvant Therapy in Resectable Esophageal Cancer
The Role of Adjuvant and Neoadjuvant Therapy in Resectable Esophageal Cancer
1,247
Total downloads
6,464
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 21 May 2025
Impact of neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy on postoperative safety in locally advanced esophageal squamous cell carcinoma: a propensity score-matched retrospective cohort study
doi 10.3389/fonc.2025.1573597
- 1,149 views
ORIGINAL RESEARCH
Published on 13 May 2025
Safety and efficacy analysis of neoadjuvant radiotherapy combined with concurrent paclitaxel plus nedaplatin versus other platinum-based chemotherapy for thoracic segmental esophageal squamous cell carcinoma
doi 10.3389/fonc.2025.1582481
- 1,092 views
ORIGINAL RESEARCH
Published on 17 Jan 2025
Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy
doi 10.3389/fonc.2024.1426592
- 1,057 views
- 2 citations
ORIGINAL RESEARCH
Published on 14 Jan 2025
Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: a two-center, propensity score matching study
doi 10.3389/fonc.2024.1463936
- 1,103 views
